Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jan;49(1):1-21.
doi: 10.1080/16506073.2018.1560358. Epub 2019 Feb 14.

Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials

Emily Carl  1 , Sara M Witcraft  2 , Brooke Y Kauffman  3 , Eilis M Gillespie  4 , Eni S Becker  5 , Pim Cuijpers  6 , Michael Van Ameringen  7 , Jasper A J Smits  1 , Mark B Powers  1   8
Affiliations
Meta-Analysis

Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials

Emily Carl et al. Cogn Behav Ther. 2020 Jan.

Abstract

The purpose of this meta-analysis was to provide updated pooled effect sizes of evidence-based psychotherapies and medications for generalized anxiety disorder (GAD) and to investigate potential moderators of outcomes. Seventy-nine randomized controlled trials (RCT) including 11,002 participants with a diagnosis of GAD were included in a meta-analysis that tested the efficacy of psychotherapies or medications for GAD. Psychotherapy showed a medium to large effect size (g = 0.76) and medication showed a small effect size (g = 0.38) on GAD outcomes. Psychotherapy also showed a medium effect on depression outcomes (g = 0.64) as did medications (g = 0.59). Younger age was associated with a larger effect size for psychotherapy (p < 0.05). There was evidence of publication bias in psychotherapy studies. This analysis found a medium to large effect for empirically supported psychotherapy interventions on GAD outcomes and a small effect for medications on GAD outcomes. Both groups showed a medium effect on depression outcomes. Because medication studies had more placebo control conditions than inactive conditions compared to psychotherapy studies, effect sizes between the domains should not be compared directly. Patient age should be further investigated as a potential moderator in psychotherapy outcomes in GAD.

Keywords: GAD; generalized anxiety disorder; medication; meta-analysis: randomized controlled trial; therapy.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
Flowchart of inclusion of studies.
Figure 2.
Figure 2.
Effect sizes of treatments for GAD in adults compared with control conditions: Hedges' g.
Figure 3.
Figure 3.
Funnel plot for psychotherapy studies with imputed studies and adjusted effect size.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alaka KJ, Noble W, Montejo A, Dueñas H, Munshi A, Strawn JR, … Ball S (2014). Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: A randomized, double-blind, placebo-controlled trial. International Journal of Geriatric Psychiatry, 29(9), 978–986. doi: 10.1002/gps.4088 - DOI - PMC - PubMed
    1. Aliyev NA, & Aliyev ZN (2008). Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: Randomized, double-blind placebo-controlled study. European Psychiatry : the Journal of the Association of European Psychiatrists, 23(2), 109–114. doi: 10.1016/j.eurpsy.2007.08.001 - DOI - PubMed
    1. Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, … Clary CM (2004). Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. The American Journal of Psychiatry, 161(9), 1642–1649. doi:10.1176/appi.ajp.161.9.1642 - DOI - PubMed
    1. Allgulander C, Hackett D, & Salinas E (2001). Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: Twenty-four-week placebo-controlled dose-ranging study. The British Journal of Psychiatry : the Journal of Mental Science, 179(1), 15–22. doi: 10.1192/bjp.179.1.15 - DOI - PubMed
    1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington DC: American Psychiatric Association.

Publication types

MeSH terms

Substances